Keep Me Logged In
Ivan Cheung, Eisai U.S. chairman and CEO, speaks exclusively with "Power Lunch" and CNBC's Meg Tirrell about the drug trial for an Alzheimer's treatment from Biogen and Eisai.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by